Hematology/Oncology

Top Story

Use of EHRs, CPOE associated with physician burnout, dissatisfaction

July 27, 2016

Physicians reported low satisfaction with their electronic health records and computerized physician order entry, according to findings published in Mayo Clinic Proceedings.

An analysis of survey data also found that physicians who used these technologies were more likely to be less satisfied and burned out.

Health Care Legislative and Regulatory Update

Are the holiday baskets really worth the risk?

July 27, 2016
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of…
In the Journals Plus

Opinions on prognosis often discordant between patients and their oncologists

July 27, 2016
Patients with advanced cancers frequently interpreted their prognoses differently from their oncologists, according to the results of a cross-sectional study published…
In the Journals

Melanoma in situ incidences increase at faster rate than invasive melanoma

July 27, 2016
Incidence of melanoma in situ increased at a faster rate than invasive melanoma, with the two melanomas displaying epidemiological and clinical differences, according to…
In the Journals

Statin use associated with dose-dependent reduction in cirrhosis and HCC in patients with HCV

July 27, 2016
In patients with hepatitis C, both atorvastatin and fluvastatin use were associated with a dose-dependent reduction in both cirrhosis and hepatocellular carcinoma…
More News Headlines »
CME

Management of Multiple Myeloma: Using Emerging Therapies with ASCT

This activity is supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Spectrum Pharmaceuticals, Inc.; and Takeda Oncology.

Multiple myeloma management has undergone profound changes in the past few decades, this is largely due to advances in…
More »
Video

VIDEO: Selecting patients for prolonged letrozole therapy requires discussion of benefits, drawbacks

July 13, 2016
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME Video

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by an educational grant from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty five percent of lung cancers are non-small…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan